Evidence-Based Cardiology (Evidence-Based Medicine)

✍ Scribed by Salim Yusuf, John Cairns, John Camm, Ernest L. Fallen, Bernard J. Gersh

• Publisher: BMJ Books
• Year: 2009
• Tongue: English
• Leaves: 1244
• Series: Evidence-Based Medicine
• Edition: 3
• Category: Library

✦ Synopsis

Evidence based Cardiology was first published in 1998 to universal acclaim. Now, with the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence-based practice is a more important force in health care delivery than ever.

This new third edition, written by the world’s leading cardiologists, provides graded evidence-based reviews of the major trials together with recommendations for optimum management, and now includes new grading and recommendation methodology.

This is a unique book in the field of cardiology, and the largest evidence based clinical cardiology text.

✦ Table of Contents

Evidence-Based Cardiology, THIRD EDITION......Page 5
Contents......Page 7
List of contributors......Page 10
Preface to the third edition......Page 16
Classification of recommendations and levels of evidence......Page 18
List of abbreviations......Page 19
Part I: General concepts and critical appraisal......Page 23
1: Evidence-based decision making: patient–physician interface......Page 25
2: Obtaining incremental information from diagnostic tests......Page 36
3: Clinical trials and meta-analysis......Page 48
4: Understanding concepts related to health economics......Page 60
5: Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention......Page 69
6: Implementing evidence-based medicine in cardiology......Page 85
7: The application of evidence-based medicine to employment fitness standards: the transportation industries with special reference to aviation......Page 101
Part II: Prevention of cardiovascular diseases......Page 115
8: Global perspective on cardiovascular disease......Page 117
9: Avoidance of worldwide vascular deaths and total deaths from smoking......Page 133
10: Tobacco and cardiovascular disease: achieving smoking cessation in cardiac patients......Page 147
11: Lipids and cardiovascular disease......Page 160
12: Use of lipid-lowering agents in the prevention of cardiovascular disease......Page 169
13: Blood pressure and cardiovascular disease......Page 187
14: Dysglycemia and the risk of cardiovascular events......Page 201
15: Physical activity and exercise in cardiovascular disease prevention and rehabilitation......Page 212
16: Psychosocial factors......Page 223
17: The social determinants of cardiovascular disease......Page 233
18: Obesity......Page 243
19: Ethnicity and cardiovascular disease......Page 257
20: Fetal origins of coronary artery disease......Page 280
21: Genetics of coronary heart disease......Page 290
22: Molecular genetics of cardiovascular disorders......Page 310
23: Diet and cardiovascular disease......Page 326
24: Integrating approaches to prevention of cardiovascular disease......Page 350
Part IIIa: Stable coronary artery disease......Page 365
25: Medical management of stable coronary artery disease......Page 367
26: Percutaneous intervention......Page 379
27: Surgical coronary artery revascularization......Page 401
28: Comparisons of percutaneous coronary intervention and coronary artery bypass grafting......Page 414
Part IIIb: Acute coronary syndromes......Page 429
29: Non-ST segment elevation acute coronary syndromes: unstable angina and non-ST segment elevation myocardial infarction......Page 431
30: Early prehospital management of ST elevation myocardial infarction......Page 466
31: Reperfusion therapies for ST segment elevation myocardial infarction......Page 478
32: Antithrombotic therapies for patients with ST segment elevation myocardial infarction......Page 497
33: Complications after myocardial infarction......Page 517
34: An integrated approach to the management of patients after the early phase of ST segment elevation myocardial infarction......Page 538
Part IIIc: Arrhythmias......Page 551
35: Atrial fibrillation: rhythm and rate control therapies......Page 553
36: Atrial fibrillation: upstream therapies......Page 590
37: Atrial fibrillation: antithrombotic therapy......Page 603
38: Ablation therapy for atrial fibrillation......Page 618
39: Supraventricular tachycardia......Page 628
40: Prevention and treatment of life-threatening ventricular arrhythmia and sudden death......Page 641
41: Pacemaker therapy, including cardiac resynchronization therapy......Page 658
42: Syncope......Page 695
43: Cardiopulmonary resuscitation......Page 714
44: Arrhythmias due to monogenic disorders......Page 728
45: Arrhythmogenic right ventricular cardiomyopathy......Page 743
Part IIId: Specific cardiovascular disorders: left ventricular dysfunction......Page 755
46: Epidemiology and prevention of heart failure and management of asymptomatic left ventricular systolic dysfunction......Page 757
47: Management of overt heart failure......Page 778
48: Acute myocarditis and dilated cardiomyopathy......Page 806
49: Management of hypertrophic cardiomyopathy......Page 818
50: Infective and infiltrative cardiomyopathies......Page 830
51: Chagas’ heart disease......Page 845
Part IIIe: Specific cardiovascular disorders: pericardial disease......Page 865
52: Pericardial disease: an evidence-based approach to clinical management......Page 867
Part IIIf: Specific cardiovascular disorders: valvular heart disease......Page 881
53: Rheumatic heart disease: prevention and acute treatment......Page 883
54: Mitral valve disease: indications for surgery......Page 891
55: Surgical indications in aortic valve disease......Page 900
56: Non-surgical aortic valve therapy: balloon valvuloplasty and transcatheter aortic valve replacement......Page 918
57: Balloon valvuloplasty: mitral valve......Page 935
58: Valve repair and choice of valve......Page 949
59: Infective endocarditis......Page 963
60: Antithrombotic therapy after heart valve replacement......Page 983
Part IIIg: Specific cardiovascular disorders: other conditions......Page 995
61: Stroke......Page 997
62: Heart disease and pregnancy......Page 1019
63: Adult congenital heart disease......Page 1032
64: Venous thromboembolic disease......Page 1058
65: Peripheral arterial disease......Page 1076
66: Cardiac risk in those undergoing non-cardiac surgery......Page 1094
67: Clinical management of diseases of the aorta......Page 1105
68: Cardiac transplantation: indications and postoperative management......Page 1125
69: Renal dysfunction......Page 1136
70: Pulmonary hypertension......Page 1144
Part IV: Clinical applications......Page 1159
71: Clinical applications of external evidence......Page 1161
72: Stable angina: choice of PCI versus CABG versus medical therapy......Page 1164
73: Non-ST segment elevation acute coronary syndrome......Page 1168
74: Acute ST segment elevation myocardial infarction......Page 1178
75: Secondary prevention strategies post myocardial infarction......Page 1183
76: Heart failure......Page 1190
77: Atrial fibrillation......Page 1196
78: The case for and against implantable cardioverter defibrillators in patients with coronary artery disease......Page 1200
79: Bradyarrhythmias–choice of pacemakers......Page 1204
80: Peripheral arterial disease with suspect coronary artery disease......Page 1209
81: Valvular heart disease: timing of surgery......Page 1213
Index......Page 1217
Colour plates......Page 964